<?xml version='1.0' encoding='utf-8'?>
<document id="19074522"><sentence text="Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase." /><sentence text="The preparation of bacterial membranes (&quot;Bactosomes&quot;) containing expressed canine (beagle) hepatic cytochromes P450 (P450s) is described" /><sentence text=" cDNAs from seven canine P450s were subcloned into inducible expression plasmids and, for the first time, cotransformed and expressed with a canine P450 oxidoreductase in Escherichia coli to produce active, full-length, native sequence P450s" /><sentence text=" Enzyme expression levels, although variable, were generally sufficient to enable short incubation times and to limit the total protein present in enzyme incubations" /><sentence text=" Steady-state kinetics of CYP1A1, 2C21, and 2D15 Bactosomes demonstrated similarities with dog liver microsomes or Baculosomes" /><sentence text=" However, 3A12 lacked substrate inhibition in the formation of 1'-OH midazolam, and 2B11 displayed non-Michaelis-Menten kinetics, suggesting possible differences in protein interaction effects"><entity charOffset="63-78" id="DDI-PubMed.19074522.s6.e0" text="1'-OH midazolam" /></sentence><sentence text=" In monitoring the metabolites of common P450 substrates, phenacetin deethylation, temazepam demethylation, and bufuralol 1'-hydroxylation were shown to be relatively selective reactions catalyzed by CYP1A1, 2B11, and 2D15, respectively"><entity charOffset="58-68" id="DDI-PubMed.19074522.s7.e0" text="phenacetin" /><entity charOffset="112-121" id="DDI-PubMed.19074522.s7.e1" text="bufuralol" /><pair ddi="false" e1="DDI-PubMed.19074522.s7.e0" e2="DDI-PubMed.19074522.s7.e0" /><pair ddi="false" e1="DDI-PubMed.19074522.s7.e0" e2="DDI-PubMed.19074522.s7.e1" /></sentence><sentence text=" 1'-OH midazolam was formed in higher quantities by CYP2B11 and 2C21 than by 3A12, raising questions about the use of midazolam as a CYP3A12 probe in vivo"><entity charOffset="1-16" id="DDI-PubMed.19074522.s8.e0" text="1'-OH midazolam" /><entity charOffset="118-127" id="DDI-PubMed.19074522.s8.e1" text="midazolam" /><pair ddi="false" e1="DDI-PubMed.19074522.s8.e0" e2="DDI-PubMed.19074522.s8.e0" /><pair ddi="false" e1="DDI-PubMed.19074522.s8.e0" e2="DDI-PubMed.19074522.s8.e1" /></sentence><sentence text=" In summary, a panel of recombinant P450s was produced to make up for the lack of commercially available canine P450 isoforms" /><sentence text=" The Bactosomes are expected to facilitate reaction phenotyping and metabolic drug-drug interaction assessment in canine drug development and to enable the study of interspecies differences in P450-mediated drug metabolism" /><sentence text="" /></document>